Year archive

Enlivex Therapeutics Ltd. — 2026 filings

All 45 regulatory filings released by Enlivex Therapeutics Ltd. (ENLV) in 2026, sourced directly from the official regulator.

45 Filings

2026 Period

2026 filings (45)

Filing	Released	Lang
Other Report or Announcement Capital/Financing Update	2026-04-22	English
Other Report or Announcement Report Publication Announcement	2026-04-22	English
Immediate Report Regulatory Filings	2026-04-21	Hebrew (modern)
Immediate Report Report Publication Announcement	2026-04-21	English
Immediate Report Regulatory Filings	2026-04-08	English
Immediate Report Report Publication Announcement	2026-04-08	English
The company's shares will be delisted from TASE on April 26, 2026, Last trading date will be April 23, 2026- Reminder Delisting Announcement	2026-04-05	English
Enlivex Posts $1.23B Profit (Net Income) For Fiscal 2025 Earnings Release FY 2025	2026-03-26	English
Enlivex Rain Update: Rain Launches an OpenClaw and AI Agent Interface Allowing Anyone To Create A Prediction Market Via A Single Prompt Regulatory Filings	2026-03-26	English
Enlivex Rain Update: Rain Launches an OpenClaw and AI Agent Interface Allowing Anyone To Create A Prediction Market Via A Single Prompt Report Publication Announcement	2026-03-26	English
FORM 20-F F0R 2025 Annual Report FY 2025	2026-03-25	English
FORM 20-F F0R 2025 Report Publication Announcement	2026-03-25	English
Enlivex Reports Full-Year 2025 Results: Earnings Release FY 2025	2026-03-25	English
Enlivex Reports Full-Year 2025 Results: Report Publication Announcement	2026-03-25	English
Enlivex Announces $21 Million Debt Financing, Decentralized Prediction Markets RAIN Token-Related Updates and $20 Million Share Repurchase Program Capital/Financing Update	2026-03-24	English
Enlivex Announces $21 Million Debt Financing, Decentralized Prediction Markets RAIN Token-Related Updates and $20 Million Share Repurchase Program Report Publication Announcement	2026-03-24	English
Enlivex Receives Investigational New Drug (IND) Clearance from the FDA for Phase 2b Trial of Allocetra in AgeRelated Primary Moderate-to-Severe Knee Osteoarthriti Regulatory Filings	2026-03-23	English
Enlivex Receives Investigational New Drug (IND) Clearance from the FDA for Phase 2b Trial of Allocetra in AgeRelated Primary Moderate-to-Severe Knee Osteoarthriti Report Publication Announcement	2026-03-23	English
Immediate Report Capital/Financing Update	2026-03-21	English
Immediate Report Report Publication Announcement	2026-03-21	English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Pomerantz Roger Director's Dealing	2026-03-19	English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Pomerantz Roger Director's Dealing	2026-03-19	English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Galamidi Einat Director's Dealing	2026-03-19	English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Galamidi Einat Director's Dealing	2026-03-19	English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Shlosberger Shachar Director's Dealing	2026-03-19	English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Shlosberger Shachar Report Publication Announcement	2026-03-19	English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Hershkovitz Oren Director's Dealing	2026-03-19	English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Hershkovitz Oren Report Publication Announcement	2026-03-19	English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-NOVIK SHAI Director's Dealing	2026-03-19	English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-NOVIK SHAI Report Publication Announcement	2026-03-19	English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Havron Avraham Director's Dealing	2026-03-19	English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Havron Avraham Regulatory Filings	2026-03-19	English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Hart Gili Director's Dealing	2026-03-19	English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Hart Gili Report Publication Announcement	2026-03-19	English
Other Report or Announcement Regulatory Filings	2026-03-14	English
Other Report or Announcement Report Publication Announcement	2026-03-14	English
Changes in the company's name and security's name, effective as of February 25, 2025 Regulatory Filings	2026-02-23	English
Change of Name to Enlivex LTD Regulatory Filings	2026-02-23	English
Change of Name to Enlivex LTD Regulatory Filings	2026-02-23	Hebrew (modern)
Results of a meeting held on February 3, 2026 AGM Information	2026-02-05	English
Results of a meeting held on February 3, 2026 Regulatory Filings	2026-02-05	English
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on WhiteBIT, a Leading Cryptocurrency Exchange Regulatory Filings	2026-01-26	English
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on WhiteBIT, a Leading Cryptocurrency Exchange Regulatory Filings	2026-01-26	English
Immediate Report Delisting Announcement	2026-01-23	English
Immediate Report Regulatory Filings	2026-01-23	English

Filings by year

2026 45 filings
2025 63 filings
2024 69 filings
2023 55 filings
2022 62 filings
2021 73 filings
2020 78 filings
2019 40 filings